Friday, December 15, 2017

What's Coming in 2018: FDA's Regulatory Agenda

Regulatory Focus-14 hours ago
The US Food and Drug Administration (FDA) published its fall 2017 agenda of proposed and final rulemakings this week, with several expected on drug compounding, allowing foreign clinical data to bring medical devices to market and new ways to market nonprescription drugs. On the compoundingfront, FDA plans to ...
Post a Comment